AstroNova settles MTEX dispute, announces strategic review as Q1 profit returns

Filed June 8, 2026 · Period ending April 30, 2026 · Compared to 10-Q Jun 6, 2025 · ~1 min read

Key Changes

• high

  Board announced formal strategic review in April 2026 to maximize shareholder value, considering sale, merger, or other transactions alongside continuing current strategy.

  MD&A: Strategic Alternatives verify on EDGAR →
• high

  MTEX arbitration settled in May 2026 via €2.5M property transfer and mutual releases, ending dispute that arose from acquisition integration challenges and alleged contract breaches.

  Legal Proceedings verify on EDGAR →
• high

  Q1 FY2027 revenue grew 4.4% to $39.4M with net income of $0.7M ($0.08/share) vs. net loss of $0.4M prior year; gross margin expanded 500 bps to 36.6% on favorable mix.

  MD&A: Financial Results verify on EDGAR →